I've never heard what the hard-core users of this forum have to say about the following (I value everyone's opinion, but I'd like to hear what LifeMirage and others have to say about this).
From Wikipedia:
An anticholinesterase is a chemical that inhibits a cholinesterase enzyme from breaking down acetylcholine, so increasing both the level and duration of action of the neurotransmitter acetylcholine.
A cholinesterase inhibitor (or "anticholinesterase") suppresses the action of the enzyme. Because of its essential function, chemicals that interfere with the action of cholinesterase are potent neurotoxins, causing excessive salivation and eye watering in low doses, followed by muscle spasms and ultimately death (examples are snake venom, sarin and VX).
That definition would justify the following:
Reminyl (i.e., AChE) Deaths Prompt Warning
New Precaution Added to Label of Alzheimer's Disease Drug
By Daniel DeNoon
WebMD Medical News Reviewed By Brunilda Nazario, MD
on Tuesday, April 05, 2005
April 5, 2005 -- The deaths of 13 elderly patients taking the Alzheimer's drug Reminyl during a study has prompted a change to the drug's label.
News of the voluntary label change was announced in a "Dear Healthcare Professional" letter from Reminyl maker Ortho-McNeil, a subsidiary of Johnson & Johnson.
Information about the deaths will be added to the "Precautions" section of Reminyl's label. There is no change in the dosage of the drug or the indications for its use.
Reminyl is approved only for the treatment of mild-to-moderate Alzheimer's disease. The studies were exploring the use of the drug for mild cognitive impairment. Mild cognitive impairment is memory loss less severe than Alzheimer's disease but more severe than would be expected based on a person's age.
In the two studies, 1,026 patients received Reminyl and 1,022 patients received a placebo. There were 13 deaths in the Reminyl group but only one death in the placebo group.
The deaths, according to the Ortho-McNeil letter, "were due to various causes, which could be expected in an elderly population." About half were due to heart attack, stroke, and sudden death.
It's not clear why there were more deaths in the Reminyl group. The letter notes that during the first six months of the two-year trials, there were no deaths in the placebo group -- "a highly unexpected finding in this population," the letter states.
Studies of patients with Alzheimer's disease do not show increased deaths among patients treated with Reminyl.
For more information about Reminyl, contact Ortho-McNeil Neurologics at (800) 526-7736.
So... with lots of folks advocating AChE inhibitors, what is everyone's thoughts on this? My own opinion? Well I'm not nearly educated enough on this topic, but if I had to take a wild stab, I'd say that because lots of people take this supplement on this forum and have yet to die then death must not be immediate. And, if only 10 more people died out of 1,026 patients than the placebo group, death must not occur in everyone. Also, the study doesn't tell what dose of the AChE's the people were taking. And we all know that for studies the doctors like to exceed the recommended dose often to get a response. So my "wild stab" would be that at certain doses, AChE supplements shouldn't be harmful... but at higher doses, they can cause death.
Thoughts?